🇺🇸 FDA
Patent

US 8466288

Isoindolinone inhibitors of phosphatidylinositol 3-kinase

granted A61PA61P21/02A61P25/00

Quick answer

US patent 8466288 (Isoindolinone inhibitors of phosphatidylinositol 3-kinase) held by Vertex Pharmaceuticals Incorporated expires Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jun 18 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P21/02, A61P25/00, A61P25/08, A61P25/14